Correlation Between Reviva Pharmaceuticals and Eagle Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Eagle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Eagle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Eagle Pharmaceuticals, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Eagle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Eagle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Eagle Pharmaceuticals.

Diversification Opportunities for Reviva Pharmaceuticals and Eagle Pharmaceuticals

0.76

Correlation Coefficient

Reviva Pharmaceuticals  Eagle Pharmaceuticals

Poor diversification

The 3 months correlation between Reviva and Eagle is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Eagle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eagle Pharmaceuticals and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Eagle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eagle Pharmaceuticals has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Eagle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Eagle Pharmaceuticals

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to under-perform the Eagle Pharmaceuticals. In addition to that, Reviva Pharmaceuticals is 3.56 times more volatile than Eagle Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Eagle Pharmaceuticals is currently generating about -0.14 per unit of volatility. If you would invest  419.00  in Eagle Pharmaceuticals on March 2, 2024 and sell it today you would lose (72.00) from holding Eagle Pharmaceuticals or give up 17.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Eagle Pharmaceuticals

Reviva Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Reviva Pharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in July 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Eagle Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eagle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Reviva Pharmaceuticals and Eagle Pharmaceuticals

The main advantage of trading using opposite Reviva Pharmaceuticals and Eagle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Eagle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eagle Pharmaceuticals will offset losses from the drop in Eagle Pharmaceuticals' long position.

The idea behind Reviva Pharmaceuticals Holdings and Eagle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.